The VEGFR2/AKT/eNOS pathway is extensively studied and closely associated with angiogenesis, as well as the occurrence and progression of cardiovascular diseases.[19] Our findings demonstrated that the administration of GXST resulted in increased expression of VEGFR2 (P = .028). The gene discussed is KDR; the disease is cardiovascular disorder.